In the absence of tissue culture, electron microscopy or assays for vi
ral antigen, the direct detection of hepatitis C virus (HCV) is by nec
essity dependent upon nucleic acid hybridisation methods. Of the avail
able methods, amplification of HCV cDNA by polymerase chain reaction (
PCR) commends itself by virtue of its extreme sensitivity and its cons
equent ability to detect the very low levels of HCV-RNA that are prese
nt in many clinical samples. In this review the development and evolut
ion of PCR techniques for HCV detection are described and a number of
clinical applications are considered in detail. The applications inclu
de diagnosis of acute infection during the seronegative window period
prior to the appearance of HCV antibodies, and diagnosis of HCV infect
ion in the immunosuppressed. PCR also enables identification of the ch
ronic viraemic carrier stale and it permits accurate monitoring of the
antiviral effects of drugs such as interferon. Confirmation of the sp
ecificity of HCV antibody assays and detection of HCV contamination of
blood donations and blood products are other important areas in which
PCR techniques have proved invaluable. In addition, PCR-based techniq
ues underlie an increasing number of molecular epidemiological and gen
otyping studies and they are providing insights into the details of HC
V cellular tropism and replication. A number of logistic problems and
operational difficulties are also discussed. Despite these limitations
it is concluded that PCR will continue to make significant contributi
ons to both clinical practice and to our understanding of the basic bi
ology of HCV infection.